Aussie cancer research to focus on molecular markers
The University of Queensland School of Dentistry’s Oral Oncology Research Program has secured a $500,000 grant to support the development of clinical and molecular diagnostics
The University of Queensland School of Dentistry’s Oral Oncology Research Program has secured a $500,000 grant to support the development of clinical and molecular diagnostics
Surgery alone is the least expensive treatment for oropharyngeal squamous cell carcinoma (OP SCCA), and chemoradiation therapy is the most expensive treatment, according to a
Mydent International Defend+Plus wipes are now available in a larger 10 x10-inch size. According to the company, Defend+Plus wipes provide a two-minute kill time against
Adding graphic warning labels on cigarette packaging can improve smokers’ recall of the warning and health risks associated with smoking, according to researchers from the
The good news is more cancer patients are surviving than ever before. The bad news is it creates new challenges for the medical community to
For the first time, scientists have defined the bacteria that inhabit multiple sites along the healthy human digestive tract in a large number of individuals.
David Raben, MD, and Antonio Jimeno, MD, of the University of Colorado Cancer Center have begun a clinical trial that tests the combination of a
ClearCorrect is collaborating with Objet to make Objet’s high-resolution, 3D printing systems part of its mass-scale manufacturing of custom-made orthodontic aligners. A number of recently
Liposuction is a novel and minimally invasive procedure for treating persistent submental lymphedema in patients with previous head and neck cancer, according to researchers from
A peer- and community-driven education program appears to be a successful vehicle to encourage high school students in Appalachia to reduce their intake of sugared
PMX-30063, a drug being developed by PolyMedix for the treatment of acute care conditions, has shown potential as a topical treatment for oral mucositis in
Patients with head and neck cancer (HNC) may be at risk for significant late effects after treatment, but they’re unlikely to discuss it with their